Startup news, 24 October 2026

2 briefs

• Pathos AI raises $237M at $3B valuation, partners with BMS on cancer drugs

  AI drug discovery startup Pathos AI has closed a $237 million Series E round at a $3 billion valuation, led by pharmaceutical company Bristol Myers Squibb. The deal reflects broader trends in the…

  Reported by siliconangle.com

• Mural secures funding to simplify cross-border payments for fintechs

  Mural, a startup building infrastructure to streamline cross-border payments, has raised $15 million in a Series A round led by Tether, with participation from North Island Ventures. The funding…

  Reported by alleywatch.com